Active Mental Health

Time-restricted eating as an adjunctive intervention for bipolar disorder

In plain English

AI plain-English summary

People with bipolar disorder often have disrupted sleep and body clocks, and no existing treatment directly targets these rhythms. Time-restricted eating—limiting food intake to a set daily window—has been shown to stabilise circadian rhythms in animals and humans, but it has never been tested in bipolar disorder. This project will run two studies. The first is a randomised controlled trial comparing time-restricted eating against a Mediterranean diet control, testing whether the intervention works best early in the illness. The second study will measure how adherence to time-restricted eating affects the daily amplitude of core clock gene expression and melatonin secretion, and how those biological changes relate to symptoms and quality of life. If successful, this work would provide a simple, low-cost, and highly acceptable intervention for bipolar disorder that patients could adopt without medication changes. It would also deliver a critical test of the circadian rhythm hypothesis of bipolar disorder—a long-standing theory that has never been directly examined through an intervention that shifts the body clock. The research is fundamental in nature: it asks whether stabilising daily biological rhythms can improve mental health, a question with implications for how we understand and treat mood disorders more broadly.

View original technical description
Extensive research indicates that sleep and biological rhythms are often disrupted among those with bipolar disorder (BD) and among their relatives, and that these biological rhythms are tied to severity of illness, to cognitive dysfunction, and to metabolic syndromes. Accordingly, there is a profound need for interventions that can stabilize biological rhythms in BD. Time-restricted eating (TRE) is an intervention shown to improve circadian rhythms in animals and humans, but it has not been tested in BD. We aim to conduct two studies to examine TRE in BD. First, we will conduct a randomized controlled trial (RCT) to examine efficacy as compared to a control intervention of the Mediterranean diet, and to test the hypothesis that the intervention will be particularly powerful early in the course of BD. Second, to understand mechanisms, we will measure how TRE adherence predicts the diurnal amplitude of core circadian clock gene expression and phase and amplitude of melatonin secretion changes after 1 month, and how amplitude of clock gene expression predicts changes in symptoms and QOL. If successful, this work will provide a novel, easily implemented and highly acceptable intervention for BD, and a critically needed test of the circadian rhythm hypothesis of BD.

View the original record at the funder ↗

Researchers

Emily Manoogian (EPMC Awardee)Erin Michalak (EPMC Awardee)Greg Murray (EPMC Awardee)Keanan Joyner (EPMC Awardee)Kenneth Allen (EPMC Awardee)Lance Kriegsfeld (EPMC Awardee)Liam Mason (EPMC Awardee)Michael Berk (EPMC Awardee)Satchidananda Panda (EPMC Awardee)Sheri Johnson (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Towards sleep and circadian diagnostic biomarkers for unipolar and bipolar depression
Ambient and passive collection of sleep and circadian rhythm data in bipolar disorder to understand symptom trajectories and clinical outcomes (AMBIENT- BD).
Validation of a translatable chronobiological signature of early relapse in bipolar disorder
Testing a causal model of sleep and circadian rhythm disturbance and youth- onset mood disorders
Randomised Controlled Trial of a Ketogenic Diet for Bipolar Depression (“Keto- BD”).

Original classification

Directed Call

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.